Nanjing Well Pharmaceutical GroupLtd Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
Nanjing Well Pharmaceutical GroupLtd has been growing earnings at an average annual rate of 0.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 10.5% per year. Nanjing Well Pharmaceutical GroupLtd's return on equity is 8.6%, and it has net margins of 11.1%.
Anahtar bilgiler
0.4%
Kazanç büyüme oranı
-1.2%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 12.1% |
| Gelir büyüme oranı | 10.5% |
| Özkaynak getirisi | 8.6% |
| Net Marj | 11.1% |
| Son Kazanç Güncellemesi | 30 Sep 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06Gelir ve Gider Dağılımı
Nanjing Well Pharmaceutical GroupLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 24 | 1,328 | 147 | 118 | 63 |
| 30 Jun 24 | 1,321 | 138 | 121 | 62 |
| 31 Mar 24 | 1,239 | 120 | 123 | 58 |
| 31 Dec 23 | 1,156 | 112 | 122 | 56 |
| 30 Sep 23 | 1,089 | 95 | 91 | 57 |
| 30 Jun 23 | 1,046 | 88 | 108 | 54 |
| 31 Mar 23 | 1,067 | 94 | 108 | 56 |
| 31 Dec 22 | 1,111 | 95 | 122 | 54 |
| 30 Sep 22 | 1,129 | 96 | 142 | 43 |
| 30 Jun 22 | 1,146 | 106 | 134 | 45 |
| 31 Mar 22 | 1,105 | 103 | 124 | 42 |
| 31 Dec 21 | 1,042 | 101 | 110 | 41 |
| 30 Sep 21 | 989 | 109 | 73 | 45 |
| 30 Jun 21 | 889 | 99 | 79 | 39 |
| 31 Mar 21 | 808 | 94 | 76 | 37 |
| 31 Dec 20 | 736 | 100 | 74 | 35 |
| 30 Sep 20 | 732 | 93 | 103 | 34 |
| 30 Jun 20 | 775 | 109 | 91 | 35 |
| 31 Mar 20 | 823 | 122 | 89 | 33 |
| 31 Dec 19 | 881 | 128 | 92 | 32 |
| 30 Sep 19 | 862 | 138 | 82 | 29 |
| 30 Jun 19 | 832 | 127 | 78 | 24 |
| 31 Mar 19 | 822 | 123 | 78 | 25 |
| 31 Dec 18 | 801 | 112 | 74 | 24 |
| 30 Sep 18 | 779 | 109 | 53 | 40 |
| 30 Jun 18 | 771 | 108 | 62 | 35 |
| 31 Mar 18 | 720 | 104 | 66 | 28 |
| 31 Dec 17 | 694 | 107 | 66 | 22 |
| 31 Dec 16 | 558 | 85 | 87 | 0 |
| 31 Dec 15 | 499 | 61 | 61 | 0 |
| 31 Dec 14 | 528 | 45 | 57 | 0 |
Kaliteli Kazançlar: 603351 has high quality earnings.
Büyüyen Kar Marjı: 603351's current net profit margins (11.1%) are higher than last year (8.7%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 603351's earnings have grown by 0.4% per year over the past 5 years.
Büyüme Hızlandırma: 603351's earnings growth over the past year (55%) exceeds its 5-year average (0.4% per year).
Kazançlar vs. Sektör: 603351 earnings growth over the past year (55%) exceeded the Chemicals industry -3.8%.
Özkaynak Getirisi
Yüksek ROE: 603351's Return on Equity (8.6%) is considered low.